Key details
Collaborators
Shenzhen Pregene Biopharma Co., Ltd.
Enrollment target
~24 participants
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 70 Years
Last updated February 2024